BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8704179)

  • 21. Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.
    Schmueck-Henneresse M; Omer B; Shum T; Tashiro H; Mamonkin M; Lapteva N; Sharma S; Rollins L; Dotti G; Reinke P; Volk HD; Rooney CM
    J Immunol; 2017 Jul; 199(1):348-362. PubMed ID: 28550199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific activation of resting T cells against CA19-9+ tumor cells by an anti-CD3/CA19-9 bispecific antibody in combination with a costimulatory anti-CD28 antibody.
    Hombach A; Tillmann T; Jensen M; Heuser C; Sircar R; Diehl V; Kruis W; Pohl C
    J Immunother; 1997 Sep; 20(5):325-33. PubMed ID: 9336739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
    Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
    Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
    J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
    Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
    Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of lymphocyte subsets and adhesion molecules in T cell-dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies.
    Renner C; Jung W; Sahin U; van Lier R; Pfreundschuh M
    Eur J Immunol; 1995 Jul; 25(7):2027-33. PubMed ID: 7621876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
    Gramzinski RA; Adams E; Gross JA; Goodman TG; Allison JP; Lefrançois L
    Int Immunol; 1993 Feb; 5(2):145-53. PubMed ID: 8383994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress is involved in the heat stress-induced downregulation of TCR zeta chain expression and TCR/CD3-mediated [Ca(2+)](i) response in human T-lymphocytes.
    Nambiar MP; Fisher CU; Enyedy EJ; Warke VG; Kumar A; Tsokos GC
    Cell Immunol; 2002 Feb; 215(2):151-61. PubMed ID: 12202152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions.
    Maccalli C; Pisarra P; Vegetti C; Sensi M; Parmiani G; Anichini A
    J Immunol; 1999 Dec; 163(12):6912-23. PubMed ID: 10586094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?
    Whiteside TL
    Cancer Immunol Immunother; 2004 Oct; 53(10):865-78. PubMed ID: 15118842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies.
    Flens MJ; Mulder WM; Bril H; von Blomberg van de Flier MB; Scheper RJ; van Lier RA
    Cancer Immunol Immunother; 1993 Oct; 37(5):323-8. PubMed ID: 8402736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2.
    Haagen IA; Geerars AJ; de Lau WB; Bast BJ; de Gast BC
    Blood; 1995 Jun; 85(11):3208-12. PubMed ID: 7538821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer.
    Kono K; Ichihara F; Iizuka H; Sekikawa T; Matsumoto Y
    Int J Cancer; 1998 Oct; 78(3):301-5. PubMed ID: 9766562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low CD3+CD28-induced interleukin-2 production correlates with decreased reactive oxygen intermediate formation in neonatal T cells.
    Kilpinen S; Hurme M
    Immunology; 1998 Jun; 94(2):167-72. PubMed ID: 9741337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
    Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
    Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
    Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes.
    McKarns SC; Kaminski NE
    Immunopharmacology; 2000 Jul; 48(2):101-15. PubMed ID: 10936508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.